| Breakdown | TTM | Nov 2025 | Nov 2024 | Nov 2023 | Nov 2022 | Nov 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 34.91B | 32.10B | 35.62B | 30.56B | 25.61B | 20.92B |
| Gross Profit | 11.46B | 10.67B | 12.15B | 11.65B | 8.81B | 6.16B |
| EBITDA | 4.68B | 3.63B | 5.89B | 5.97B | 4.02B | 1.99B |
| Net Income | 3.03B | 2.04B | 3.90B | 3.95B | 2.37B | 1.22B |
Balance Sheet | ||||||
| Total Assets | 18.25B | 18.40B | 18.53B | 19.15B | 14.27B | 7.88B |
| Cash, Cash Equivalents and Short-Term Investments | 7.86B | 7.52B | 8.76B | 11.96B | 8.85B | 3.09B |
| Total Debt | 564.12M | 1.12B | 590.94M | 644.58M | 649.05M | 1.65B |
| Total Liabilities | 6.47B | 6.58B | 6.69B | 6.50B | 5.61B | 5.18B |
| Stockholders Equity | 11.78B | 11.82B | 11.83B | 12.65B | 8.66B | 2.70B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 953.81M | 2.27B | 3.19B | 3.31B | 1.70B |
| Operating Cash Flow | 0.00 | 2.26B | 4.39B | 3.91B | 3.56B | 1.94B |
| Investing Cash Flow | 0.00 | -1.94B | -2.43B | -805.52M | -365.00M | -257.33M |
| Financing Cash Flow | 0.00 | -1.56B | -5.16B | 2.14M | 2.57B | -617.64M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥199.56B | 6.74 | ― | 4.01% | -2.39% | -4.54% | |
75 Outperform | ¥57.16B | 23.79 | ― | 4.61% | -4.72% | -40.77% | |
74 Outperform | ¥245.23B | 12.14 | 14.00% | 5.13% | 3.27% | -1.81% | |
71 Outperform | ¥70.51B | 12.60 | 9.22% | 6.15% | 7.45% | 45.25% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
62 Neutral | ¥80.59B | 24.43 | 10.06% | 3.75% | 20.36% | 9.29% | |
43 Neutral | ¥171.33B | 13.27 | 7.26% | 4.16% | 14.69% | -114.36% |